Vivoryon Therapeutics N.V. (AMS:VVY)
Netherlands · Delayed Price · Currency is EUR 1.310
-0.010 (-0.76%)
Mar 27, 2026, 5:35 PM CET
Vivoryon Therapeutics Market Cap
Vivoryon Therapeutics has a market cap or net worth of €39.09 million as of March 27, 2026. Its market cap has decreased by -22.06% in one year.
Market Cap
39.09M
Enterprise Value
34.33M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.31
Market Cap Chart
Since October 27, 2014, Vivoryon Therapeutics's market cap has decreased from 135.32M to 39.09M, a decrease of -71.11%. That is a compound annual growth rate of -10.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 39.09M | -7.04% |
| Dec 31, 2025 | 42.05M | -18.93% |
| Dec 31, 2024 | 51.87M | -75.55% |
| Dec 29, 2023 | 212.18M | -14.71% |
| Dec 30, 2022 | 248.77M | -34.60% |
| Dec 31, 2021 | 380.39M | 111.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Value8 | 61.95M |
| Global InterConnection Group | 60.58M |
| Ebusco Holding | 57.07M |
| BM3EAC | 54.19M |
| Morefield Group | 50.22M |
| New Amsterdam Invest | 46.65M |
| Cabka | 44.48M |
| Bever Holding NV | 42.64M |